CING
Cingulate Inc.
Key Financials
Net Income
$-22449911
↓ 44.4%
Operating Income
$-19938108
↓ 27.4%
Total Assets
$15.1M
↑ 1.4%
Total Liabilities
$12.6M
↑ 69.6%
EPS (Diluted)
$-4.44
↑ 56.5%
Cash & Equivalents
$11.0M
↓ 10.3%
Shareholders' Equity
$2.5M
↓ 66.3%
Operating Cash Flow
$-17245182.00
↑ 6.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 6/16/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 3 | 6/8/2026 | View on SEC |
| 8-K | 6/2/2026 | View on SEC |
| DEF 14A | 5/29/2026 | View on SEC |
| ARS | 5/29/2026 | View on SEC |
| DEFA14A | 5/29/2026 | View on SEC |
| 8-K | 5/19/2026 | View on SEC |
| PRE 14A | 5/18/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CING |
| Company Name | Cingulate Inc. |
| CIK | 1862150 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (913) 942-2300 |